311 related articles for article (PubMed ID: 30247950)
1. Complementary Treatment with Mistletoe Extracts During Chemotherapy: Safety, Neutropenia, Fever, and Quality of Life Assessed in a Randomized Study.
Pelzer F; Tröger W; Nat DR
J Altern Complement Med; 2018; 24(9-10):954-961. PubMed ID: 30247950
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy and safety of long-term complementary treatment with standardized European mistletoe extract (Viscum album L.) in addition to the conventional adjuvant oncologic therapy in patients with primary non-metastasized mammary carcinoma. Results of a multi-center, comparative, epidemiological cohort study in Germany and Switzerland].
Bock PR; Friedel WE; Hanisch J; Karasmann M; Schneider B
Arzneimittelforschung; 2004; 54(8):456-66. PubMed ID: 15460213
[TBL] [Abstract][Full Text] [Related]
3. Impact of complementary mistletoe extract treatment on quality of life in breast, ovarian and non-small cell lung cancer patients. A prospective randomized controlled clinical trial.
Piao BK; Wang YX; Xie GR; Mansmann U; Matthes H; Beuth J; Lin HS
Anticancer Res; 2004; 24(1):303-9. PubMed ID: 15015612
[TBL] [Abstract][Full Text] [Related]
4. Retrolective, comparative, epidemiological cohort study with parallel groups design for evaluation of efficacy and safety of drugs with "well-established use".
Bock PR; Friedel WE; Hanisch J; Karasmann M; Schneider B
Forsch Komplementarmed Klass Naturheilkd; 2004 Aug; 11 Suppl 1():23-9. PubMed ID: 15353899
[TBL] [Abstract][Full Text] [Related]
5. [Adjuvant simultaneous mistletoe chemotherapy in breast cancer--influence on immunological parameters, quality of life and tolerability].
Loewe-Mesch A; Kuehn JJ; Borho K; Abel U; Bauer C; Gerhard I; Schneeweiss A; Sohn C; Strowitzki T; v Hagens C
Forsch Komplementmed; 2008 Feb; 15(1):22-30. PubMed ID: 18334811
[TBL] [Abstract][Full Text] [Related]
6. Intratumoral Mistletoe (Viscum album L) Therapy in Patients With Unresectable Pancreas Carcinoma: A Retrospective Analysis.
Schad F; Atxner J; Buchwald D; Happe A; Popp S; Kröz M; Matthes H
Integr Cancer Ther; 2014 Jul; 13(4):332-40. PubMed ID: 24363283
[TBL] [Abstract][Full Text] [Related]
7. Use and safety of intratumoral application of European mistletoe (Viscum album L) preparations in Oncology.
Steele ML; Axtner J; Happe A; Kröz M; Matthes H; Schad F
Integr Cancer Ther; 2015 Mar; 14(2):140-8. PubMed ID: 25552476
[TBL] [Abstract][Full Text] [Related]
8. Quality of life in breast cancer patients during chemotherapy and concurrent therapy with a mistletoe extract.
Eisenbraun J; Scheer R; Kröz M; Schad F; Huber R
Phytomedicine; 2011 Jan; 18(2-3):151-7. PubMed ID: 20724129
[TBL] [Abstract][Full Text] [Related]
9. Quality of life and neutropenia in patients with early stage breast cancer: a randomized pilot study comparing additional treatment with mistletoe extract to chemotherapy alone.
Tröger W; Jezdić S; Zdrale Z; Tišma N; Hamre HJ; Matijašević M
Breast Cancer (Auckl); 2009 Jul; 3():35-45. PubMed ID: 21556248
[TBL] [Abstract][Full Text] [Related]
10. Quality of life, immunomodulation and safety of adjuvant mistletoe treatment in patients with gastric carcinoma - a randomized, controlled pilot study.
Kim KC; Yook JH; Eisenbraun J; Kim BS; Huber R
BMC Complement Altern Med; 2012 Oct; 12():172. PubMed ID: 23033982
[TBL] [Abstract][Full Text] [Related]
11. Mistletoe therapy in oncology.
Horneber MA; Bueschel G; Huber R; Linde K; Rostock M
Cochrane Database Syst Rev; 2008 Apr; 2008(2):CD003297. PubMed ID: 18425885
[TBL] [Abstract][Full Text] [Related]
12. Randomised and non-randomised prospective controlled cohort studies in matched-pair design for the long-term therapy of breast cancer patients with a mistletoe preparation (Iscador): a re-analysis.
Grossarth-Maticek R; Ziegler R
Eur J Med Res; 2006 Nov; 11(11):485-95. PubMed ID: 17182361
[TBL] [Abstract][Full Text] [Related]
13. Prospective controlled cohort studies on long-term therapy of breast cancer patients with a mistletoe preparation (Iscador).
Grossarth-Maticek R; Ziegler R
Forsch Komplementmed; 2006 Oct; 13(5):285-92. PubMed ID: 17057389
[TBL] [Abstract][Full Text] [Related]
14. Prospective controlled cohort studies on long-term therapy of ovairian cancer patients with mistletoe (Viscum album L.) extracts iscador.
Grossarth-Maticek R; Ziegler R
Arzneimittelforschung; 2007; 57(10):665-78. PubMed ID: 18074761
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant Cancer Biotherapy by Viscum Album Extract Isorel: Overview of Evidence Based Medicine Findings.
Sunjic SB; Gasparovic AC; Vukovic T; Weiss T; Weiss ES; Soldo I; Djakovic N; Zarkovic T; Zarkovic N
Coll Antropol; 2015 Sep; 39(3):701-8. PubMed ID: 26898069
[TBL] [Abstract][Full Text] [Related]
16. Impact of complementary treatment of breast cancer patients with standardized mistletoe extract during aftercare: a controlled multicenter comparative epidemiological cohort study.
Beuth J; Schneider B; Schierholz JM
Anticancer Res; 2008; 28(1B):523-7. PubMed ID: 18383896
[TBL] [Abstract][Full Text] [Related]
17. Patients are talking about ... Iscador (mistletoe).
Decker G
Clin J Oncol Nurs; 2001; 5(4):183-4. PubMed ID: 12690624
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of the long-term adjuvant treatment of primary intermediate- to high-risk malignant melanoma (UICC/AJCC stage II and III) with a standardized fermented European mistletoe (Viscum album L.) extract. Results from a multicenter, comparative, epidemiological cohort study in Germany and Switzerland.
Augustin M; Bock PR; Hanisch J; Karasmann M; Schneider B
Arzneimittelforschung; 2005; 55(1):38-49. PubMed ID: 15727163
[TBL] [Abstract][Full Text] [Related]
19. Safety of high-dose intravenous mistletoe therapy in pediatric cancer patients: A case series.
Zuzak TJ; Wasmuth A; Bernitzki S; Schwermer M; Längler A
Complement Ther Med; 2018 Oct; 40():198-202. PubMed ID: 30219449
[TBL] [Abstract][Full Text] [Related]
20. Effect of Withania somnifera (Ashwagandha) on the development of chemotherapy-induced fatigue and quality of life in breast cancer patients.
Biswal BM; Sulaiman SA; Ismail HC; Zakaria H; Musa KI
Integr Cancer Ther; 2013 Jul; 12(4):312-22. PubMed ID: 23142798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
